ПОРУШЕННЯ БАЛАНСУ ПРО-ТА ПРОТИЗАПАЛЬНИХ ЦИТОКІНІВ У ПАЦІЄНТІВ З ЛЕГЕНЕВОЮ ГІПЕРТЕНЗІЄЮ НА ТЛІ ХРОНІЧНОГО ОБСТРУКТИВНОГО ЗАХВОРЮВАННЯ ЛЕГЕНЬ З СУПУТНЬОЮ ІШЕМІЧНОЮ ХВОРОБОЮ СЕРЦЯ

Journal Title: World Science - Year 2018, Vol 2, Issue 8

Abstract

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease of the lung associated with progressive airflow limitation. There is growing recognition that the inflammatory state associated with COPD is not confined to the lungs but also involves the systemic circulation and can impact nonpulmonary organs. However, there is insufficient data on the potential role of systemic inflammation in the formation of pulmonary hypertension, secondary to COPD. Thus, our goal was to investigate the degree of systemic inflammation that is reflected in the level of interleukin-4 and interleukin (IL-2) exchange in patients with COPD and coronary artery disease (IHD) with and without pulmonary hypertension. METHODS: 121 patients with COPD and stable coronary heart disease (mean age [M +/- SD], 60.7 ± 9.7 years, mean FEV1, 46.2 ± 18.1%) were screened into the study, mean pulmonary artery preasure was measured using echocardiography. Osteopontin and IL-2 levels in the serum were evaluated using ELISA kits. Patients were divided into 2 groups: 1 group with signs of pulmonary hypertension (68 patients); and 53 patients without Pulmonary hypertension (2-group). RESULTS: IL-2 concentrations were in 1 group - 9.8 [7.3; 13.1] and 2.2 [0.9; 3.0] in 2 group respectively. For IL-4, the levels were 2.5 [1.8; 2.9] – 1 group, and in the control group (without PH) 3.5 [0.59; 10.0] does not exceed the values of healthy donors. Correlation analysis shows that in the first group there was a positive correlation between the duration of COPD and the level of IL-2 (r = 0.33, p = 0.04) and the negative correlation between osteopontin, IL -2 with a FEV1 (r = -0.84); FLC (r = -0.55). There is a high correlation between osteopontin (r = -0.45), IL-2 (r = -0.60), and a 6-minute walk test and IL-2 and the Borg dyspnea scale (r = 0, 42) after a 6-minute walk test. Pulmonary hypertension is associated with increased levels of systemic inflammatory markers which may have important pathophysiological and therapeutic implications for subjects with stable COPD and CAD.

Authors and Affiliations

О. А. Гетман, О. О. Крахмалова

Keywords

Related Articles

AZERBAIJANI LITERATURE COSMOLOGICAL AND MYTHOLOGICAL THINKING - RELIGIOUS MOTIVES

The article deals with the cosmic consciousness of Azerbaijani poets, writers and scientists. It is analyzed how famous writers skillfully used cosmic consciousness in their works. Also, similar subjects of works of anci...

THE ROLE OF THEORETICAL KNOWLEDGE IN THE DEVELOPMENT OF THE METHODOLOGY OF SCIENTIFIC RESEARCH

In the article the interrelation of theoretical knowledge and research methodology in the process of development of science is considered. The essence of the concept "theory" is disclosed, the unity of theory and practic...

КОГНІТИВНА МОДЕЛЬ ТА МЕТОД УПРАВЛІННЯ ПОКАЗНИКАМИ ПРОФЕСІЙНОЇ АКТИВНОСТІ НАВЧАЛЬНО-ПЕДАГОГІЧНИХ ПРАЦІВНИКІВ ДЛЯ ПІДВИЩЕННЯ КОНКУРЕНТОЗДАТНОСТІ ВИПУСКНИКІВ УНІВЕРСИТЕТУ

В роботі проведено аналіз впливу на параметри навчального процесу у вищому навчальному закладі вимог до науково-педагогічних працівників, закріплених у ліцензійних умов провадження освітньої діяльності закладів освіти. П...

CLINICAL DEFINITION OF RISK FACTORS FOR COMPLICATION DEVELOPMENT AT PROSTHETICS WITH PARTIAL INTERCHANGABLE LAMINAR PROSTHESES

Efficiency assessment for using partial interchangeable laminar prostheses was conducted for patients with generalized parodontitis, as well as risk factors for complication development was defined at 93 patients with ch...

Download PDF file
  • EP ID EP545490
  • DOI 10.31435/rsglobal_ws/30082018/6063
  • Views 90
  • Downloads 0

How To Cite

О. А. Гетман, О. О. Крахмалова (2018). ПОРУШЕННЯ БАЛАНСУ ПРО-ТА ПРОТИЗАПАЛЬНИХ ЦИТОКІНІВ У ПАЦІЄНТІВ З ЛЕГЕНЕВОЮ ГІПЕРТЕНЗІЄЮ НА ТЛІ ХРОНІЧНОГО ОБСТРУКТИВНОГО ЗАХВОРЮВАННЯ ЛЕГЕНЬ З СУПУТНЬОЮ ІШЕМІЧНОЮ ХВОРОБОЮ СЕРЦЯ. World Science, 2(8), 26-35. https://europub.co.uk./articles/-A-545490